| 35th week of 2016 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20160250224 | OREXIN-CONTROL OF BONE FORMATION AND LOSS | 2016-09-01 |
| 20160250225 | ENHANCED BIMATOPROST OPHTHALMIC SOLUTION | 2016-09-01 |
| 20160250226 | DERMAL DELIVERY COMPOSITIONS AND METHODS | 2016-09-01 |
| 20160250227 | METHOD AND COMPOSITION FOR TRANSDERMAL DRUG DELIVERY | 2016-09-01 |
| 20160250229 | CERCLAGE PESSARY CONTAINING PROGESTERONE OF PROLONGED, SUSTAINED, AND CONTINUOUS RELEASE USEFUL FOR PREVENTION OF PRETERM BIRTH | 2016-09-01 |
| 20160250230 | THERMO-KINETIC MIXING FOR PHARMACEUTICAL APPLICATIONS | 2016-09-01 |
| 20160250231 | SOLID DRUG IMPLANTS FOR INTRACOCHLEAR DELIVERY OF THERAPEUTICS FOR THE TREATMENT OF OTIC DISORDERS | 2016-09-01 |
| 20160250232 | A DELAYED RELEASE DRUG FORMULATION | 2016-09-01 |
| 20160250233 | ANTIVIRAL DRUGS FOR TREATMENT OR PREVENTION OF DENGUE INFECTION | 2016-09-01 |
| 20160250234 | Method of Treating Endometrial Tissue Disease by Altering an Epithelial to Mesenchymal Transition | 2016-09-01 |
| 20160250235 | CALCIUM GLYCEROPHOSPHATE FOR TREATING AND PREVENTING RESPIRATORY DISEASES OR CONDITIONS | 2016-09-01 |
| 20160250236 | PREDICTIVE BIOMARKER FOR HYPOXIA-ACTIVATED PRODRUG THERAPY | 2016-09-01 |
| 20160250237 | SOFT PROTEASE INHIBITORS AND PRO-SOFT FORMS THEREOF | 2016-09-01 |
| 20160250238 | Method for the Prophylaxis or Treatment of Systemic Lupus Erythematosus and/or Lupus Nephritis | 2016-09-01 |
| 20160250239 | FEED SUPPLEMENT COMPRISING OLIGOSACCHARIDES AND MEDIUM CHAIN FATTY ACIDS | 2016-09-01 |
| 20160250240 | METHODS AND COMPOSITIONS FOR PROMOTING ACTIVITY OF ANTI-CANCER THERAPIES | 2016-09-01 |
| 20160250241 | NICOTINAMIDE RIBOSIDE COMPOSITIONS FOR TOPICAL USE IN TREATING SKIN CONDITIONS | 2016-09-01 |
| 20160250242 | HYPERSULFATED DISACCHARIDE FORMULATIONS | 2016-09-01 |
| 20160250243 | USE OF ICARITIN IN PREPARING MEDICAMENT FOR PREVENTING OR TREATING HEMATOCYTOPENIA | 2016-09-01 |
| 20160250244 | COMPOSITIONS FOR TREATING HEARTWORM INFESTATION | 2016-09-01 |
| 20160250245 | Methods and Pharmaceutical Composition for the Treatment of Polyomavirus Infections | 2016-09-01 |
| 20160250246 | ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF | 2016-09-01 |
| 20160250247 | VITAMIN B6 DERIVATIVES OF NUCLEOTIDES, ACYCLONUCLEOTIDES AND ACYCLONUCLEOSIDE PHOSPHONATES | 2016-09-01 |
| 20160250248 | METHOD FOR GENERATION OF BROADLY NEUTRALIZING ANTI-PATHOGEN ANTIBODIES | 2016-09-01 |
| 20160250249 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING AUTOPHAGY IN A SUBJECT IN NEED THEREOF | 2016-09-01 |
| 20160250250 | SKIN COMPOSITIONS AND METHODS OF USE THEREOF | 2016-09-01 |
| 20160250251 | LOW FREQUENCY GLATIRAMER ACETATE THERAPY | 2016-09-01 |
| 20160250252 | BIOACTIVE GAS-ENCAPSULATED ECHOGENIC LIPOSOMES AND METHODS FOR TREATING CARDIOVASCULAR DISEASE | 2016-09-01 |
| 20160250253 | STRONTIUM-CONTAINING COMPLEXES FOR TREATING GASTROESOPHAGEAL REFLUX AND BARRETT'S ESOPHAGUS | 2016-09-01 |
| 20160250254 | METHODS OF REDUCING DOSES OF ERYTHROPOIETIN STIMULATING AGENTS IN HYPORESPONSIVE PATIENTS | 2016-09-01 |
| 20160250255 | METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC REGULATORY T CELLS | 2016-09-01 |
| 20160250256 | TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS | 2016-09-01 |
| 20160250257 | ISOLATION, CULTIVATION AND USES OF STEM/PROGENITOR CELLS | 2016-09-01 |
| 20160250258 | MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF | 2016-09-01 |
| 20160250259 | METHODS AND DEVICES FOR OBTAINING AND PROVIDING COMBINATION CELL THERAPY | 2016-09-01 |
| 20160250260 | SMALL MOLECULE CELLULAR REPROGRAMMING TO GENERATE NEURONAL CELLS | 2016-09-01 |
| 20160250261 | CARDIAC NEURAL CREST CELLS AND METHODS OF USE THEREOF | 2016-09-01 |
| 20160250262 | CRYOPRESERVATION, HIBERNATION AND ROOM TEMPERATURE STORAGE OF ENCAPULATED PANCREATIC ENDODERM CELL AGGREGATES | 2016-09-01 |
| 20160250263 | METHOD FOR PREPARING OF ENDOTHELIAL CELLS BY TRANSFORMATION (TRANSDIFFERENTIATION) OF ADULT FIBROBLAST, AND USE THEREOF | 2016-09-01 |
| 20160250264 | EXTRACT OF TAIWANESE PROPOLIS FOR TREATING OCULAR DISEASES | 2016-09-01 |
| 20160250265 | NON-REPLICATING PROBIOTIC MICRO-ORGANISMS PROTECT AGAINST UPPER RESPIRATORY TRACT INFECTIONS | 2016-09-01 |
| 20160250266 | PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME | 2016-09-01 |
| 20160250267 | ONCOLYTIC HSV VECTOR | 2016-09-01 |
| 20160250268 | METHOD OF TREATING A MALIGNANCY IN A SUBJECT AND A PHARMACEUTICAL COMPOSITION FOR USE IN SAME | 2016-09-01 |
| 20160250269 | Feed Supplement and a Feed Composition Comprising Resin Acid Based Composition | 2016-09-01 |
| 20160250270 | COMPOSITIONS COMPRISING COMBINATIONS OF PURIFIED CANNABINOIDS, WITH AT LEAST ONE FLAVONOID, TERPENE, OR MINERAL | 2016-09-01 |
| 20160250271 | HERBAL COMPOSITION FOR DIABETIC RETINOPATHY | 2016-09-01 |
| 20160250272 | ANTIANGIOGENIC USE OF LIQUID PHYTOCOMPLEXES FROM OLIVE | 2016-09-01 |
| 20160250273 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF "PLAQUES AND TANGLES" IN HUMANS AND ANIMALS | 2016-09-01 |
| 20160250274 | Protective Effects of Oil Palm Composition on Alzheimer's Disease | 2016-09-01 |
| 20160250275 | EXTRACT OF ZINIGIBER ZERUMBET FOR DIABETIC RETINOPATHY | 2016-09-01 |
| 20160250276 | LISSENCEPHALY THERAPEUTIC AGENT | 2016-09-01 |
| 20160250278 | PEPTIDOMIMETIC MACROCYCLES | 2016-09-01 |
| 20160250279 | Composition for Treating and Preventing Benign Prostatic Hyperplasia | 2016-09-01 |
| 20160250280 | Uses Of Cyclic Peptides For Treating And Preventing AtherosclerosisUses of Cyclic Peptides for Treating and Preventing Atherosclerosis | 2016-09-01 |
| 20160250281 | Peptide for Suppressing and Treating Obesity | 2016-09-01 |
| 20160250282 | Novel therapeutical tools and methods for treating blindness | 2016-09-01 |
| 20160250283 | COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND THERAPY OF CLOSTRIDIUM DIFFICILE INFECTION | 2016-09-01 |
| 20160250284 | METHODS FOR TREATING RESTENOSIS USING ANNEXIN A5 | 2016-09-01 |
| 20160250285 | NEUROPROTECTIVE PEPTIDES | 2016-09-01 |
| 20160250286 | CONTROL OF RHEOLOGICAL PROPERTIES OF MIXED HYALURONATE/LUBRICIN SOLUTIONS | 2016-09-01 |
| 20160250287 | METHODS OF TREATING AND PREVENTING CANCER DRUG RESISTANCE | 2016-09-01 |
| 20160250288 | NERVE REGENERATING OR NERVE GROWTH-PROMOTING PHARMACEUTICAL COMPOSITION CONTAINING VAX PROTEIN AS ACTIVE INGREDIENT | 2016-09-01 |
| 20160250289 | Galectin-3C Combination Therapy for Human Cancer | 2016-09-01 |
| 20160250290 | GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE | 2016-09-01 |
| 20160250291 | COMPOSITION FOR PREVENTING OR TREATING AMYOTROPHIC LATERAL SCLEROSIS USING TWO OR MORE ISOFORMS OF HEPATOCYTE GROWTH FACTOR | 2016-09-01 |
| 20160250292 | In Vivo Individualized Systemic Immunotherapeutic Method and Device | 2016-09-01 |
| 20160250293 | COMPOSITION FOR EXTERNAL PREPARATION FOR SKIN | 2016-09-01 |
| 20160250294 | COMPOSITION-OF-MATTER AND METHOD FOR TREATING CARDIOVASCULAR DISORDERS | 2016-09-01 |
| 20160250295 | FORMULATION FOR GONADOTROPINS | 2016-09-01 |
| 20160250296 | METHODS OF TREATING INFERTILITY | 2016-09-01 |
| 20160250297 | Diketopiperazine salts for drug delivery and related methods | 2016-09-01 |
| 20160250298 | INCLUSION BODIES FOR TRANSDERMAL DELIVERY OF THERAPEUTIC AND COSMETIC AGENTS | 2016-09-01 |
| 20160250299 | Use of Alkaline Phosphatase for Preserving Renal Function | 2016-09-01 |
| 20160250300 | METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION | 2016-09-01 |
| 20160250301 | LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME | 2016-09-01 |
| 20160250302 | Compositions and Methods for Safe Treatment of Rhinitis | 2016-09-01 |
| 20160250303 | PERFORIN-2 ACTIVATORS AND INHIBITORS AS DRUG TARGETS FOR INFECTIOUS DISEASE AND GUT INFLAMMATION | 2016-09-01 |
| 20160250304 | CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME | 2016-09-01 |
| 20160250305 | Method for Immunomodulation of using Aza-podophyllotoxin derivatives | 2016-09-01 |
| 20160250306 | POLYVALENT CONJUGATE VACCINE FOR CANCER | 2016-09-01 |
| 20160250307 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS | 2016-09-01 |
| 20160250308 | SEMI-ALLOGENIC ANTI-TUMOUR VACCINE WITH HLA HAPLO-IDENTICAL ANTIGEN-PRESENTING CELLS | 2016-09-01 |
| 20160250309 | COMPOSITIONS AND METHODS FOR CANCER TREATMENT | 2016-09-01 |
| 20160250310 | GALECTIN-3 AS IMMUNOLOGICAL TARGET | 2016-09-01 |
| 20160250311 | DNA VACCINE FOR USE IN PANCREATIC CANCER PATIENTS | 2016-09-01 |
| 20160250312 | MALARIA VACCINATION | 2016-09-01 |
| 20160250313 | FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A | 2016-09-01 |
| 20160250314 | COMPOSITIONS AND METHODS FOR DETECTING, TREATING, AND PROTECTING AGAINST FUSOBACTERIUM INFECTION | 2016-09-01 |
| 20160250315 | HUMAN PAPILLOMA VIRUS THERAPEUTIC VACCINE | 2016-09-01 |
| 20160250316 | IMMUNOGENIC POLYPEPTIDES COMPRISING A SCAFFOLD POLYPEPTIDE AND A L2 POLYPEPTIDE OR A FRAGMENT THEREOF | 2016-09-01 |
| 20160250317 | SCHMALLENBERG VIRUS (SBV) VACCINE, METHODS OF PRODUCTION, AND USES THEREOF | 2016-09-01 |
| 20160250318 | BIVALENT SWINE INFLUENZA VIRUS VACCINE | 2016-09-01 |
| 20160250319 | THERMOSTABLE RESPIRATORY SYNCTIAL VIRUS (RSV) VACCINE COMPOSITIONS | 2016-09-01 |
| 20160250320 | IMMUNOREGULATORY PEPTIDES AND METHODS OF USE | 2016-09-01 |
| 20160250321 | NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANT | 2016-09-01 |
| 20160250322 | VECTOR CO-EXPRESSING VACCINE AND COSTIMULATORY MOLECULES | 2016-09-01 |
| 20160250323 | Particles Comprising a Shell with RNA | 2016-09-01 |
| 20160250324 | VACCINE COMPOSITION COMPRISING AN IMMUNOGENIC PROTEIN AND COMBINATION ADJUVANTS FOR USE IN ELICITING ANTIGEN-SPECIFIC T-CELL RESPONSES | 2016-09-01 |
| 20160250325 | ADJUVANT COMPOUND | 2016-09-01 |
